Psychedelic-Assisted Psychotherapy
KETAMINE
Currently, ketamine-assisted psychotherapy (KAP) is the only psychedelic-assisted psychotherapy that we are legally able to offer. If you want to be put on our waitlist for KAP, please fill out the form below and we will contact you when there is an opening. While there is extensive evidence of the efficacy of ketamine for a number of psychological concerns, this use of the medicine is still considered “off-label”. As such, the use of ketamine in this way is not covered by insurance.
You can find details about KAP here.
MDMA
MDMA-assisted therapy has been deemed a “breakthrough therapy” by the FDA given strong evidence across multiple studies showing its efficacy for treatment-resistant PTSD. To learn more about this therapy and the protocol, click here.
We are awaiting site approval from MAPS and the FDA to offer MDMA as part of an expanded access protocol, which would allow us to provide MDMA-assisted therapy in advance of full FDA approval. Care received through expanded access will unfortunately not be covered by insurance, so we will be working hard to raise funds and apply for grants so that out-of-pocket expenses will be minimal.
We are currently the only site in the city of Philadelphia planning to offer this incredible MDMA therapy protocol. We aim to make this treatment as accessible as possible to those who need it most. We feel that Philadelphia is the perfect city to create a center that aims to treat marginalized populations, including BIPOC, LGBTQIA, and neurodiverse individuals. We have had an outpouring of support from our local community and from people throughout the city of Philadelphia; we can’t wait to see where this takes us!
PSILOCYBIN
As clinical evidence of psilocybin-assisted psychotherapy’s efficacy for depression and other indications paves the road for eventual FDA approval, we look forward to the day that we can offer this therapy to our patients. Currently, we are one of four psychedelic facilitation training programs approved to train providers in psilocybin therapy. Starting in Spring 2023, we will also host week-long psilocybin-assisted therapy retreats at our partner site in Jamaica. To learn more, sign up here.
Psychedelic Integration
Ketamine-assisted psychotherapy remains the only legal psychedelic we can provide in a therapy context. While we do not provide or condone the use of illegal substances, we acknowledge that some individuals may choose to take these substances outside of a medically advised context, despite the legal and medical risks associated with recreational use of psychedelics. We currently have a clinical center in West Philadelphia PA but will soon be offering services in several other locations such as Kingston, New York (upstate NY / Hudson Valley), New York City, Eugene Oregon.
Regardless of how psychedelic experiences are attained, at SoundMind we believe that everyone deserves a confidential, non-judgmental, and therapeutic space in which to process these experiences and their potential for healing. Our integration services provide such a space, administered by clinicians with specific training for working with non-ordinary states of consciousness.
If you’d like to be put on our waitlist for any of these, please fill out the form below. To be kept updated about our offerings, please join our mailing list.